MangoRx acquires global patent portfolio from Intramont Technologies, Inc. to enter preventive care market
Acquiring Company
Mangoceuticals
Acquired Company
Intramont Technologies
DallasHackensackOtherBiotechnologyHealth CareDietary SupplementsNutritionBiotechnologyHealth CareDescription
MangoRx, Inc. (NASDAQ: MGRX) has successfully acquired a global patent portfolio from Intramont Technologies, Inc., enabling its entrance into the non-prescription nutraceutical products market. This strategic acquisition is aimed at revolutionizing preventive care for oral and respiratory health.
Quick answer
Mangoceuticals is acquiring Intramont Technologies, announced April 25, 2024. Mangoceuticals is based in Dallas, Texas, United States.
- How much did Mangoceuticals pay for Intramont Technologies?
- The deal value was not disclosed.
- What does Mangoceuticals do?
- MangoRX is a new men’s health and wellness company dedicated to developing, marketing, and selling a variety of men’s wellness products and services via a telemedicine platform that connects consumers to licensed..
- Where are Mangoceuticals and Intramont Technologies based?
- Mangoceuticals is based in Dallas, Texas, United States. Intramont Technologies is based in Hackensack, New Jersey, United States.
- Who are the decision-makers at Mangoceuticals?
- Fundz holds 1 contact at Mangoceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Dietary Supplements and Nutrition
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zinzino acquires assets in Xelliss - strategic reinforcement in southern Europe and in the microalgae spirulina (May 12, 2024)
- MangoRx Acquires Revolutionary Preventive Care Technology from Intramont Technologies (June 4, 2024)
- CoreFX Ingredients expands portfolio with acquisition of Connoils (May 28, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- Alcanza Clinical Research completes acquisition of North Georgia Clinical Research to enhance research participation opportunities (June 3, 2024)
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
Who to call at Mangoceuticals, and when
When Mangoceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Mangoceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mangoceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mangoceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mangoceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Intramont Technologies?
Intramont Technologies was acquired by Mangoceuticals, based in Dallas. The deal was reported on April 25, 2024. Mangoceuticals is publicly traded (MGRX) and operates in Other.
When did Mangoceuticals acquire Intramont Technologies?
Mangoceuticals's acquisition of Intramont Technologies was reported on April 25, 2024. MangoRx, Inc. (NASDAQ: MGRX) has successfully acquired a global patent portfolio from Intramont Technologies, Inc., enabling its entrance into the non-prescription nutraceutical products market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Intramont Technologies do?
Intramont Technologies, Inc. is the original owner of the global patent portfolio acquired by MangoRx. It is privately held, operating in Biotechnology, and is based in Hackensack.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.